SYNTHETIC CANNABIS
Synthetic cannabinoids are not derived from a plant, instead they are synthetically or “laboratory-derived” so that there is 100% consistency and predictability; just like a prescription drug. OVATION can leverage its completed research and development using plant-based cannabinoids (hemp and marijuana) in order to partner with a pharmaceutical company seeking a better delivery of their synthetic CBD or THC. Synthetic cannabis allows for approval of the finished products as a prescription pharmaceutical drug by Health Canada and the US FDA.
ANIMAL HEALTH
People across the globe are looking at cannabis as a solution to their pet health and wellness concerns. OVATION products are compatible for the animal health and will offer benefits for this growing market.
Discover The Future
We are disrupting the market with an advanced science-based technology resulting in enhanced topical products